AlphaGen Therapeutics
United States · Founded 2023
- Founded
- 2023
- Business Model
- B2B
- Website
- alphagentx.com
- Last Round
- Series AAug 2025
- Rounds
- 2
About
Radiopharmaceutical company pioneering discovery and development of innovative targeted radioligand therapies for cancer treatment.
Summary
AlphaGen Therapeutics is a Biotech company based in United States, founded in 2023. Its most recent funding was a Series A round in Aug 2025. Investors include Eight Roads Ventures and F-Prime Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...